1. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large intermittent intravenous doses;Bergsagel;Canad. Med. Ass. J.,1968
2. Phase I trials of WR2721 and chemotherapy;Glick,1983
3. Phase I clinical trials of WR-2721 with alkylating agent chemotherapy;Glick;Int. J. Radiat. Oncol. Biol. Phys.,1982
4. Clinical trials of WR-2721 with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinum;Kligerman;Cancer Clin. Trials,1981
5. Sensitizers and protectors in clinical oncology;Phillips;Semin. Oncol.,1981